Prenetics Global Limited (PRE)

4,9100 -0,2200 (-4,29%) Börsenschluss: 04:00PM EDT

Prenetics Global Limited

Unit 701-706
K11 Atelier King’s Road 728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Sheng Wu Yeung	Co-Founder, Chairperson & CEO	N/A	N/A	1979
Dr. Chi Hung Tzang Ph.D.	Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	1975
Mr. Hoi Chun Lo	Chief Financial Officer	N/A	N/A	1985
Dr. Yung Ho Wong DPHIL	Chief Technology Officer	N/A	N/A	1982
Ms. Samantha Kwok	Chief of Staff to Group CEO & Vice President, People & Operations	N/A	N/A	N/A
Dr. Senthil Sundaram M.D.	Chief Clinical Officer	N/A	N/A	1974
Mr. Joel Neoh	Chief Consumer Officer & Chief Executive Officer for CircleDNA	N/A	N/A	N/A
Mr. Walt Ling	Chief Executive Officer of ACT Genomics	N/A	N/A	N/A

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Corporate Governance

Prenetics Global Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.